Till startsida
University of Gothenburg
Sitemap
To content Read more abput how we use cookies on gu.se

PhD Theses

Anna Gustafsson-Lutz, Chemist.
Development of targeted alpha therapy with Bi-213 and At-211 for the treatment of disseminated cancer - Synthesis and evaluation of pretargeting components and radioimmunoconjugates. Institute of Clinical Sciences. Sahlgrenska Academy.
University of Gothenburg.
Year: 2016.

 

 

Elin Cederkrantz, Physicist.
Pharmacokinetics and dosimetry in intraperitoneal radioimmunotherapy with At-211. Institute of Clinical Sciences.
Sahlgrenska Academy.
University of Gothenburg.
Year: 2014.

 

 

 

Karin Magnander, Physicist.
Formation and Repair of
Complex DNA Damage Induced
by Ionizing Radiation
Institute of Clinical Sciences.
Sahlgrenska Academy.
University of Gothenburg.
Year: 2013.

 

 

Sofia Frost, Chemist.
Pretargeting agents and 211At-labeled effector molecules. Synthesis and preclinical evaluation for pretargeted alpha-radioimmunotherapy.
Institute of Clinical Sciences.
Sahlgrenska Academy.
University of Gothenburg.
Year: 2012.

Press release (in Swedish) and thesis.

 

Kristina Claesson, Physicist.
Radiobiological effects of alpha-particles from Astatine-211. From DNA damage to cell death.
Institute of Clinical Sciences.
Sahlgrenska Academy.
University of Gothenburg.
Year: 2011.

 

 

 

Tom Bäck, Biomedical Scientist.
Alpha-radioimmunotherapy with At-211. Evaluation and imaging of normal tissues and tumors.
Institute of Clinical Sciences.
Sahlgrenska Academy.
University of Gothenburg.
Year: 2011.

 

 

Jörgen Elgqvist, Physicist.
Astatine-211 radioimmunotherapy of ovarian cancer – therapeutic efficacy, myelotoxicity, and radiation dosimetry in an animal model.
Institute of Clinical Sciences.
Sahlgrenska Academy.
University of Gothenburg.
Year: 2006.

 


Sture Lindegren, Chemist.
Astatine-211 and iodine conjugates: Radiohalogenation and preclinical pharmacokinetics for targeted and pretargeted radioimmunotherapy.
Department of Nuclear Chemistry,
Chalmers University of Technology.
Year: 2002.

 

 

Håkan Andersson, Physician.
Radioimmunotherapy of experimental ovarian cancer with astatine-211 – a model for consolidation treatment in women.
Department of Oncology,
University of Gothenburg.
Year: 2000.

 

 

 

Stig Palm, Physicist.
In vitro effects and microdosimetry of astatine-211 for tumour therapy.
Institute of Clinical Sciences.
Sahlgrenska Academy.
University of Gothenburg.
Year: 1999.

 

 


 

Page Manager: Emma Aneheim|Last update: 5/13/2016
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?